Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins

Clinical Reviews in Allergy and Immunology

Volumn 34, Issue 1, 2008, Pages 16-20

  Bizzaro, Nicola ^a   Tampoia, Marilina ^b  

^a Ospedale Civile   (Italy)

^b POLICLINICO   (Italy)

Author keywords

CCP; Citrullinated peptides; Comparative study; Diagnostic accuracy; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ANTIBODY DETECTION; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; LABORATORY AUTOMATION; REVIEW; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PEPTIDES, CYCLIC; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 46749143708     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8027-0     Document Type: Review

References (42)

1. E Girbal-Neuhauser JJ Durieux M Arnaud 1999 The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues J Immunol 162 585 594
2. GA Schellekens BA de Jong FH van den Hoogen 1998 Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 273 281
3. T Cantaert L De Rycke T Bongartz 2006 Citrullinated proteins in rheumatoid arthritis. Crucial...but not sufficient Arthritis Rheum 54 3381 3389
4. RL Nienhuis E Mandema 1964 A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor Ann Rheum Dis 23 302 305
5. Hoet RM, van Venrooij WJ (1992) The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In: Smolen JS, Kalden JR, Maini RN (eds) Rheumatoid arthritis. Springer, Berlin, p 299-318
6. BJ Young RK Mallya RD Leslie 1979 Antikeratin antibodies in rheumatoid arthritis Br Med J 2 97 99
7. M Sebbag M Simon C Vincent 1995 The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies J Clin Invest 95 2672 2679
8. L Nogueira M Sebbag C Vincent 2001 Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis Ann Rheum Dis 60 882 887
9. C Vincent L Nogueira M Sebbag 2002 Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis Arthritis Rheum 46 2051 2058
10. N Bizzaro P Pasini G Mazzanti 2002 Combined use of the anti-filaggrin and anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis Autoimmunity Rev 1 65
11. GA Schellekens H Visser BA de Jong 2000 The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 155 163
12. N Bizzaro G Mazzanti E Tonutti 2001 Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 47 1089 1093
13. WJ van Venrooij JM Hazes H Visser 2002 Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis Neth J Med 60 383 388
14. K Suzuki T Sawada A Murakami 2003 High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis Scand J Rheumatol 32 197 204
15. DM Lee PH Schur 2003 Clinical utility of the anti-CCP assay in patients with rheumatic diseases Ann Rheum Dis 62 870 874
16. GC Pinheiro MA Scheinberg M Aparecida da Silva 2003 Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis Ann Intern Med 139 234 235
17. A Vasishta 2002 Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies Am Clin Lab 21 34 36
18. FA van Gaalen H Visser TW Huizinga 2005 A comparison of the diagnostic accuracy and prognostic value of the first- and second anti-cyclic citrullinated peptides autoantibody (CCP1 and CCP2) tests for rheumatoid arthritis Ann Rheum Dis 64 1510 1512
19. A Greiner H Plischke H Kellner 2005 Association of anti-cyclic citrullinated peptide antibodies, anti-citrulline antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis Ann NY Acad Sci 1050 295 303
20. A Fernandez-Suarez S Reneses I Wichmann 2005 Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis Clin Chem Lab Med 43 1234 1239
21. S Dubucquoi E Solau-Gervais D Lefranc 2004 Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases Ann Rheum Dis 63 415 419
22. S Grootenboer-Mignot P Nicaise-Roland C Delaunay 2004 Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other antifilaggrin antibodies and improve rheumatoid arthritis diagnosis Scand J Rheumatol 33 218 220
23. A Kastbom G Strandberg A Lindroos 2004 Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) Ann Rheum Dis 63 1085 1089
24. MK Soderlin A Kastbom H Kautiainen 2004 Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity Scand J Rheumatol 33 185 188
25. MM Nielen D van Schaardenburg HW Reesink 2004 Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors Arthritis Rheum 50 380 386
26. S Rantapaa-Dahlqvist BA de Jong E Berglin 2003 Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 48 2741 2749
27. K Forslind M Ahlmen K Eberhardt 2004 Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis 63 1090 1095
28. I Vallbracht J Rieber M Oppermann 2004 Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis Ann Rheum Dis 63 1079 1084
29. W Hueber BA Kidd BH Tomooka 2005 Antigen microarray profiling of autoantibodies in rheumatoid arthritis Arthritis Rheum 52 2645 2655
30. TW Huizinga CI Amos AH van der Helm-van Mil 2005 Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins Arthritis Rheum 52 3433 3438
31. FA Van Gaalen J van Aken TWJ Huizinga 2004 Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum 50 2113 2121
32. JA Hill J Sidney A Sette 2005 DRB1*1501 which does not contain the classic shared epitope sequence can bind citrullinated peptides with high affinity and supports anti-citrullinated peptide antibody (ACPA) production in rheumatoid arthritis patients [abstract] Arthritis Rheum 52 Suppl 9 S150
33. S Chapuy-Regaud M Sebbag D Baeten 2005 Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides J Immunol 174 5057 5064
34. D Baeten E Kruithof L De Rycke 2004 Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients Arthritis Rheum 50 2931 2941
35. J Avouac L Gossec M Dougados 2006 Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review Ann Rheum Dis 65 845 851
36. B Garcia-Berrocal C Gonzalez M Perez 2005 Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor positive patients Clin Chim Acta 354 123 130
37. M Tampoia V Brescia A Fontana 2005 Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations Chim Clin Acta 355 137 144
38. R Tozzoli N Bizzaro E Tonutti 2002 Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods Clin Chem Lab Med 40 568 572
39. National Committee for Clinical Laboratory Standards (1999) Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. NCCLS, Wayne, PA
40. W Hueber PJ Utz L Steinman 2002 Autoantibody profiling for the study and treatment of autoimmune disease Arthritis Res 4 290 295
41. WH Robinson L Steinman PJ Utz 2002 Proteomics technologies for the study of autoimmune disease Arthritis Rheum 46 885 893
42. W Hueber PJ Utz WH Robinson 2003 Autoantibodies in early arthritis: advances in diagnosis and prognostication Clin Exp Rheumatol 21 S59 S64